Economic and clinical burden of managing transfusion-dependent β-thalassemia in the United States

Chuka Udezea Health Economics and Outcomes Research, Vertex Pharmaceuticals Incorporated, Boston, MA, USAView further author information

Kristin A. Evansb Real World Data Research & Analytics, Merative, Cambridge, MA, USA

Yoojung Yanga Health Economics and Outcomes Research, Vertex Pharmaceuticals Incorporated, Boston, MA, USAView further author information

Timothy Lillehaugenb Real World Data Research & Analytics, Merative, Cambridge, MA, USAView further author information

Janna Manjelievskaiab Real World Data Research & Analytics, Merative, Cambridge, MA, USAView further author information

Urvi Mujumdara Health Economics and Outcomes Research, Vertex Pharmaceuticals Incorporated, Boston, MA, USAView further author information

Nanxin Lia Health Economics and Outcomes Research, Vertex Pharmaceuticals Incorporated, Boston, MA, USAView further author information

Biree Andemariamc Division of Hematology-Oncology, University of Connecticut Health, Farmington, CT, USACorrespondence[email protected]
View further author information

Your download is now in progress and you may close this window